Xie, Han
Zhang, Yuan
Zhu, Zunyi
Wei, Jingxuan
Ainiwaer, Gulinigeer
Ge, Weihong
Funding for this research was provided by:
National Natural Science Foundation of China (72104105)
Special Fund for Clinical Research of Nanjing Drum Tower Hospital (2021-LCYJ-PY-07)
Clinical Comprehensive Drugs Evaluation in Jiangsu Province
Article History
Received: 26 October 2023
Accepted: 20 December 2023
First Online: 18 January 2024
Declarations
:
: Han Xie, Yuan Zhang, Zunyi Zhu, Jingxuan Wei, Gulinigeer Ainiwaer, and Weihong Ge report no conflicts of interest.
: This study was approved by the Ethics Committee of Nanjing Drum Tower Hospital (2021-402-02), and the entire trial was conducted under strict adherence to the Good Clinical Practice Guidelines of the International Council of Harmonization and the Declaration of Helsinki. All subjects gave written informed consent.